Natriuretic peptides (B-type natriuretic peptide, BNP and N-terminal-pro-BNP, and NT-proBNP) have been routinely used for the diagnosis, prognosis, and therapeutic management of patients with cardiovascular diseases, and mainly, congestive heart failure (CHF) [1]. This evidence concerns the gene NPPB and cardiovascular disorder.